Please login to the form below
Trial boost for Novo's IDegLira ambitions
Company says drug shows weight benefits and low risk of hypoglycaemia
Publicis builds North American portfolio
Latest acquisition is digital marketing services agency Hawkeye
AZ launches combination diabetes drug in UK
Xigduo combines Forxiga and metformin
J&J adds Manchester to partnering network
Adds satellite office for London innovation hub
GSK raises stake in Indian subsidiary
Company eyes long-term growth of market
Pharma payments to US doctors down
Follows intensified public scrutiny and introduction of the Sunshine Act
Draftfcb Healthcare rebrands and acquires Halesway
The US agency will operate as FCB Health
FDA scrutiny of alirocumab hits Regeneron and Sanofi
Regulator to assess neurocognitive effects of cholesterol drug
EMA to restrict use of domperidone and diacerein
Regulator's pharmacovigilance advisors also want insomnia drug zolpidem's labelling tightened up
Translational pharmacology: the key to ensuring safe and effective dosing
Designing pharmacokinetic and toxicokinetic studies during preclinical and early phase 1 trials will maximise a candidate’s chance of safety and efficacy success
-
Use data responsiblyIt’s imperative that opening up clinical trial data doesn’t compromise patient safety
-
Pharma’s four options for innovationOnly genuinely creative companies will profit from the future
-
New data puts Jakafi on course for blockbuster statusNovartis/Incyte drug meets targets in blood cancer trial
-
Pfizer recalls depression drug in USWrong medicine found in bottle of Effexor XR
-
J&J gets EU green light for novel TB drugSirturo approved to treat multidrug resistant form of the disease
-
Novartis' dermatology plans advance with Xolair approvalGreen light for use in chronic spontaneous urticaria
-
Diabetes awards programme launchesQiC Diabetes 2014 premiered at Diabetes UK conference
-
INC Research acquires Middle Eastern CRO
Purchase of MEK Consulting expands its geographic footprint
-
BMS' novel HIV drug clears phase II trialEntry inhibitor BMS-660368 moves closer to first-in-class approval
Latest appointments
-
Owen Mumford appoints Judith CharlesShe joins medial device company as sales and marketing director
-
Isgro boosts senior teamBettina Weber joins German communications agency
-
Roche appoints new oncology research headWilliam Pao leaves academia for pharma role
-
Oxford Pharmascience adds to boardJohn Goddard is former head of group strategic planning and business at AstraZeneca
-
Stallergenes appoints Christian Chavy CEOHe will replace Roberto Gradnik at the end of this month
Featured jobs
- Account Manager / (Senior) Analyst – Market Access
- Up to £45,000 plus bonus
- Account Director - Medical Education
- Competitive + excellent benefits
- Account Director – PR Healthcare
- Excellent salary and package
- Brand Manager - Oncology - South East
- Excellent Basic, Bonus and Benefits
- Business Development Director
- Competitive Salary Offered
- Account Director
- up to 60k
- Senior Production Editor opportunity in Oxfordshire. Salary up to £65, 000.
- Salary up to £65,000
- Account Director- Healthcare
- Highly Competitive Salary
- Account Manager - Healthcare PR/ Comms
- £Competitive + excellent benefits
- Senior Account Executive / Account Manager - Healthcare Advertising - London
- £30000 - £39000 + Bonus + Benefits
- Marketing Manager UK & Ireland - Bagshot, Surrey
- Circa £60,000 + benefits
- Account Associate
- On application
- Client Director, Healthcare, Dublin
- Competitive salary, plus benefits
Subscribe to our email news alerts
PMHub
Publicis Life Brands Resolute
Publicis Life Brands Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team...
Latest intelligence
- NICE and ‘ultra orphans’
- NICE and its processes for ‘highly specialised therapies’...
- Trust is key to online engagement
- In social media it underlines the value of HCP networks...
- Compulsory evaluation in France
- French authorities will expect robust health economic cases to be made for some drugs...
Quick links
